PR01.03 A Novel 27-Gene Signature Associated with Better Outcomes for NSCLC Patients Treated with IO Therapies with PD-L1 Expression >50%.
- Resource Type
- Abstract
- Source
- In
Journal of Thoracic Oncology January 2021 16(1) Supplement:S41-S41 - Subject
- Language
- ISSN
- 1556-0864